150668-82-9

Basic information

• Product Name: 3,3-DIMETHYLPIPERIDIN-4-ONE
• Synonyms: 3,3-DIMETHYLPIPERIDIN-4-ONE;4-Piperidinone, 3,3-diMethyl-;3,3-DiMethyl-4-Piperidinone.HCl;3,3-Dimethylpiperidine-4-one;3,3-Dimethyl-4-piperidone
• CAS NO: 150668-82-9
• Molecular Formula: C₇H₁₃NO
• Molecular Weight: 127.18
• Mol File: 150668-82-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 186.2±15.0 °C(Predicted)
• Appearance: /
• Density: 0.925±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.02±0.40(Predicted)
• CAS DataBase Reference: 3,3-DIMETHYLPIPERIDIN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-DIMETHYLPIPERIDIN-4-ONE(150668-82-9)
• EPA Substance Registry System: 3,3-DIMETHYLPIPERIDIN-4-ONE(150668-82-9)

Safety Data

• Hazardous Substances Data: 150668-82-9(Hazardous Substances Data)

Usage

General Description

3,3-Dimethylpiperidin-4-one is a chemical compound with the molecular formula C8H15NO. It is a piperidinone derivative, which is a building block for a variety of pharmaceuticals and organic compounds. This chemical is commonly used as a reagent in organic synthesis and as a catalyst in chemical reactions. It is also utilized in the production of drugs and agrochemicals. Additionally, 3,3-dimethylpiperidin-4-one is known for its ability to act as an intermediate in the synthesis of other complex molecules, making it a valuable compound in the field of organic chemistry.

Upstream product

• 324769-06-4 tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate 
• 173186-91-9 N-benzyl-3,3-dimethylpiperidine-4-one 

Downstream Products

• 324769-06-4 tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate 
• 1247885-05-7 3,3-dimethyl-1-tosylpiperidin-4-one 
• 936329-33-8 1-(4-chlorobenzyl)-3,3-dimethylpiperidine-4-one 

Relevant articles and documents

Syntheses of isotopically labeled versions and major metabolites of CCR1 antagonist MLN3897

MLN3897 citrate is a novel CCR1 antagonist that was taken into development for treatment of chronic inflammatory diseases such as multiple sclerosis and rheumatoid arthritis. Non-clinical data had indicated extensive metabolism of MLN3897 via N-dealkylati

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF

Provided herein are compounds and methods of synthesis thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders, psychiatric disorders, neuromuscular disorders, gastrointestinal disorders, lower urinary tract disorder, and cancer. Compounds provided herein modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery. Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.

Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments

This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.